ArticleJournal of medical case reports2026
Emergence of central sleep apnea at high altitude in patients with mild obstructive sleep apnea: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPatients with obstructive sleep apnea ascending to high altitude are known to experience worsening of sleep-disordered breathing, often with an increase in central events. However, the management of a full phenotypic shift from mild obstructive sleep apnea to severe central sleep apnea at altitude remains poorly characterized. CASE PRESENTATION: We report a case of a 44-year-old Han Chinese man with symptomatic mild obstructive sleep apnea (apnea-hypopnea index: 11.4 events/hour) well-controlled on continuous positive airway pressure at low altitude. Upon ascent to Lhasa (3650 m), he developed severe symptoms. Diagnostic polysomnography revealed severe sleep apnea (apnea-hypopnea index: 120.1 events/hour) comprised almost exclusively of central events (central apnea index: 110.4 events/hour). A structured therapeutic evaluation was undertaken: Continuous positive airway pressure titration failed to resolve the central sleep apnea (apnea-hypopnea index: 123.5 events/hour). In contrast, combined continuous positive airway pressure and supplemental oxygen (3 L/minute) effectively normalized breathing (apnea-hypopnea index: 5.6 events/hour). A subsequent trial of acetazolamide monotherapy was also ineffective (apnea-hypopnea index: 129.9 events/hour). The patient remained well on long-term combined continuous positive airway pressure and oxygen therapy.
conclusionThis case illustrates that patients with only mild obstructive sleep apnea at sea level can develop severe, predominant central sleep apnea at high altitude. It further demonstrates that such severe high-altitude central sleep apnea may be refractory to both continuous positive airway pressure and acetazolamide monotherapy but can be effectively controlled with a combination of continuous positive airway pressure and supplemental oxygen. The findings underscore the importance of re-evaluating sleep apnea phenotype at altitude and adopting a pathophysiology-guided, individualized approach to therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.